Edward Melanson
Concepts (370)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Energy Metabolism | 57 | 2026 | 935 | 8.090 |
Why?
| | Exercise | 53 | 2026 | 2201 | 4.600 |
Why?
| | Weight Loss | 30 | 2026 | 836 | 4.470 |
Why?
| | Energy Intake | 32 | 2025 | 499 | 3.360 |
Why?
| | Calorimetry, Indirect | 21 | 2025 | 83 | 2.930 |
Why?
| | Obesity | 33 | 2026 | 3077 | 2.500 |
Why?
| | Fasting | 9 | 2025 | 277 | 2.060 |
Why?
| | Caloric Restriction | 8 | 2025 | 127 | 2.000 |
Why?
| | Thermogenesis | 6 | 2024 | 45 | 1.860 |
Why?
| | Overweight | 15 | 2026 | 609 | 1.750 |
Why?
| | Calorimetry | 11 | 2026 | 72 | 1.550 |
Why?
| | Weight Reduction Programs | 6 | 2025 | 136 | 1.440 |
Why?
| | Adipose Tissue, Brown | 3 | 2024 | 59 | 1.390 |
Why?
| | Dietary Fats | 8 | 2026 | 314 | 1.390 |
Why?
| | Sleep | 17 | 2026 | 901 | 1.300 |
Why?
| | Breakfast | 2 | 2020 | 20 | 1.280 |
Why?
| | Eating | 12 | 2022 | 389 | 1.230 |
Why?
| | Body Composition | 23 | 2026 | 706 | 1.230 |
Why?
| | Meals | 5 | 2020 | 130 | 1.200 |
Why?
| | Accelerometry | 7 | 2026 | 119 | 1.100 |
Why?
| | Resistance Training | 6 | 2024 | 182 | 1.010 |
Why?
| | Oxygen Consumption | 13 | 2025 | 724 | 0.980 |
Why?
| | Basal Metabolism | 9 | 2026 | 62 | 0.930 |
Why?
| | Diet | 9 | 2025 | 1273 | 0.900 |
Why?
| | Adult | 77 | 2026 | 40449 | 0.830 |
Why?
| | Walking | 10 | 2025 | 545 | 0.830 |
Why?
| | Gonadotropin-Releasing Hormone | 4 | 2024 | 212 | 0.810 |
Why?
| | Circadian Rhythm | 13 | 2024 | 514 | 0.810 |
Why?
| | Premenopause | 3 | 2020 | 123 | 0.810 |
Why?
| | Oxygen Isotopes | 5 | 2021 | 24 | 0.800 |
Why?
| | Estradiol | 2 | 2018 | 533 | 0.780 |
Why?
| | Monitoring, Physiologic | 6 | 2024 | 289 | 0.780 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2024 | 156 | 0.770 |
Why?
| | Body Mass Index | 21 | 2026 | 2438 | 0.760 |
Why?
| | Behavior Therapy | 3 | 2021 | 299 | 0.750 |
Why?
| | Female | 92 | 2026 | 78271 | 0.750 |
Why?
| | Humans | 127 | 2026 | 144759 | 0.740 |
Why?
| | Lipid Metabolism | 5 | 2012 | 527 | 0.740 |
Why?
| | Exercise Therapy | 5 | 2025 | 473 | 0.730 |
Why?
| | Dietary Carbohydrates | 8 | 2019 | 151 | 0.730 |
Why?
| | Time Factors | 23 | 2026 | 7173 | 0.730 |
Why?
| | Dietary Proteins | 7 | 2019 | 136 | 0.710 |
Why?
| | Water | 4 | 2024 | 469 | 0.710 |
Why?
| | Body Weight | 11 | 2021 | 976 | 0.700 |
Why?
| | Sleep Deprivation | 9 | 2021 | 206 | 0.670 |
Why?
| | Ovary | 3 | 2020 | 228 | 0.660 |
Why?
| | Middle Aged | 49 | 2026 | 35875 | 0.660 |
Why?
| | Male | 89 | 2026 | 72315 | 0.660 |
Why?
| | Reference Standards | 1 | 2020 | 177 | 0.630 |
Why?
| | Estrogens | 2 | 2024 | 380 | 0.620 |
Why?
| | Cancer Survivors | 2 | 2022 | 327 | 0.610 |
Why?
| | Exercise Test | 10 | 2024 | 634 | 0.600 |
Why?
| | Weight Gain | 10 | 2024 | 556 | 0.590 |
Why?
| | Adipose Tissue, White | 1 | 2018 | 43 | 0.560 |
Why?
| | Pulmonary Gas Exchange | 2 | 2018 | 119 | 0.560 |
Why?
| | Exercise Tolerance | 3 | 2025 | 283 | 0.550 |
Why?
| | Arthroplasty, Replacement, Knee | 4 | 2025 | 370 | 0.550 |
Why?
| | Appetite | 5 | 2025 | 69 | 0.550 |
Why?
| | Young Adult | 25 | 2025 | 14105 | 0.530 |
Why?
| | Fats | 3 | 2009 | 17 | 0.530 |
Why?
| | Physical Exertion | 5 | 2018 | 207 | 0.520 |
Why?
| | Isotope Labeling | 1 | 2017 | 82 | 0.510 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2019 | 194 | 0.480 |
Why?
| | Rest | 4 | 2018 | 124 | 0.460 |
Why?
| | Leuprolide | 1 | 2015 | 21 | 0.460 |
Why?
| | Cross-Over Studies | 10 | 2026 | 601 | 0.460 |
Why?
| | Oxidation-Reduction | 11 | 2019 | 1087 | 0.440 |
Why?
| | Muscle, Skeletal | 6 | 2014 | 1795 | 0.440 |
Why?
| | Autonomic Nervous System Diseases | 2 | 2025 | 34 | 0.420 |
Why?
| | Hunger | 2 | 2021 | 57 | 0.420 |
Why?
| | Mass Spectrometry | 1 | 2017 | 750 | 0.420 |
Why?
| | Cold Temperature | 3 | 2024 | 209 | 0.410 |
Why?
| | Reproducibility of Results | 14 | 2025 | 3409 | 0.400 |
Why?
| | Fatty Acids | 3 | 2012 | 450 | 0.370 |
Why?
| | Monitoring, Ambulatory | 4 | 2017 | 88 | 0.370 |
Why?
| | Breast Neoplasms | 2 | 2022 | 2452 | 0.360 |
Why?
| | Feeding Behavior | 6 | 2025 | 684 | 0.350 |
Why?
| | Parkinson Disease | 3 | 2025 | 600 | 0.350 |
Why?
| | Appetite Regulation | 3 | 2021 | 31 | 0.350 |
Why?
| | Temperature | 1 | 2014 | 679 | 0.340 |
Why?
| | Thinness | 1 | 2012 | 99 | 0.340 |
Why?
| | Deglutition | 5 | 2014 | 72 | 0.340 |
Why?
| | Heart Rate | 7 | 2025 | 855 | 0.320 |
Why?
| | Wearable Electronic Devices | 2 | 2024 | 63 | 0.320 |
Why?
| | Activities of Daily Living | 4 | 2018 | 441 | 0.310 |
Why?
| | Adaptation, Physiological | 4 | 2026 | 570 | 0.310 |
Why?
| | Perception | 1 | 2013 | 377 | 0.310 |
Why?
| | Melatonin | 5 | 2023 | 163 | 0.300 |
Why?
| | Carbon Dioxide | 2 | 2010 | 242 | 0.300 |
Why?
| | Work Schedule Tolerance | 3 | 2020 | 51 | 0.290 |
Why?
| | Food | 3 | 2024 | 149 | 0.290 |
Why?
| | Body Weight Maintenance | 2 | 2019 | 17 | 0.290 |
Why?
| | Lipid Peroxidation | 1 | 2009 | 160 | 0.280 |
Why?
| | Posture | 5 | 2016 | 196 | 0.270 |
Why?
| | Adaptation, Psychological | 1 | 2013 | 717 | 0.270 |
Why?
| | Weight Lifting | 2 | 2009 | 32 | 0.260 |
Why?
| | Spectrum Analysis | 3 | 2019 | 93 | 0.260 |
Why?
| | Menopause | 2 | 2022 | 320 | 0.250 |
Why?
| | Anorexia Nervosa | 2 | 2005 | 79 | 0.250 |
Why?
| | Cardiovascular Diseases | 3 | 2024 | 2168 | 0.240 |
Why?
| | Gastrointestinal Microbiome | 3 | 2026 | 771 | 0.240 |
Why?
| | Regression Analysis | 4 | 2025 | 1003 | 0.240 |
Why?
| | Wakefulness | 5 | 2020 | 169 | 0.240 |
Why?
| | Carbohydrate Metabolism | 3 | 2006 | 60 | 0.240 |
Why?
| | Adolescent | 16 | 2026 | 22428 | 0.240 |
Why?
| | Bicycling | 2 | 2025 | 120 | 0.240 |
Why?
| | Diet, Vegetarian | 1 | 2025 | 10 | 0.240 |
Why?
| | Metabolic Syndrome | 1 | 2009 | 354 | 0.230 |
Why?
| | Calcium, Dietary | 1 | 2005 | 53 | 0.230 |
Why?
| | Deuterium | 4 | 2021 | 100 | 0.230 |
Why?
| | Shoes | 5 | 2017 | 18 | 0.230 |
Why?
| | Delay Discounting | 1 | 2025 | 29 | 0.220 |
Why?
| | Ghrelin | 5 | 2025 | 38 | 0.220 |
Why?
| | Mastication | 4 | 2014 | 12 | 0.220 |
Why?
| | Physical Endurance | 3 | 2009 | 278 | 0.220 |
Why?
| | Sports Equipment | 1 | 2004 | 9 | 0.220 |
Why?
| | Eyeglasses | 1 | 2024 | 24 | 0.210 |
Why?
| | Signal Processing, Computer-Assisted | 3 | 2017 | 151 | 0.210 |
Why?
| | Double-Blind Method | 3 | 2019 | 2029 | 0.210 |
Why?
| | Osteoarthritis, Knee | 2 | 2025 | 279 | 0.200 |
Why?
| | Guidelines as Topic | 1 | 2025 | 267 | 0.200 |
Why?
| | Consensus | 1 | 2025 | 488 | 0.200 |
Why?
| | Cardiorespiratory Fitness | 2 | 2024 | 72 | 0.200 |
Why?
| | Physical Fitness | 2 | 2013 | 209 | 0.190 |
Why?
| | HIV Integrase | 1 | 2024 | 74 | 0.190 |
Why?
| | Motor Activity | 3 | 2019 | 721 | 0.190 |
Why?
| | Health Behavior | 2 | 2025 | 785 | 0.190 |
Why?
| | HIV Integrase Inhibitors | 1 | 2024 | 78 | 0.190 |
Why?
| | Biomarkers | 5 | 2024 | 4271 | 0.190 |
Why?
| | Puberty | 2 | 2014 | 140 | 0.180 |
Why?
| | Positron-Emission Tomography | 1 | 2024 | 323 | 0.180 |
Why?
| | Bariatric Surgery | 1 | 2026 | 242 | 0.180 |
Why?
| | Insulin Resistance | 4 | 2019 | 1241 | 0.180 |
Why?
| | Research Design | 2 | 2025 | 1135 | 0.180 |
Why?
| | Obesity, Morbid | 1 | 2026 | 281 | 0.180 |
Why?
| | Peptide YY | 4 | 2025 | 25 | 0.180 |
Why?
| | Circadian Clocks | 2 | 2019 | 59 | 0.180 |
Why?
| | Bone Density | 2 | 2015 | 482 | 0.170 |
Why?
| | Diet, Fat-Restricted | 3 | 2011 | 79 | 0.170 |
Why?
| | France | 1 | 2021 | 40 | 0.170 |
Why?
| | Bone Remodeling | 1 | 2021 | 71 | 0.170 |
Why?
| | Analysis of Variance | 6 | 2021 | 1306 | 0.170 |
Why?
| | Aging | 2 | 2012 | 1966 | 0.160 |
Why?
| | Fruit | 1 | 2021 | 152 | 0.160 |
Why?
| | Diabetes Mellitus | 1 | 2009 | 1098 | 0.160 |
Why?
| | Vegetables | 1 | 2021 | 170 | 0.160 |
Why?
| | Glucose | 2 | 2024 | 1047 | 0.160 |
Why?
| | Nitrogen | 2 | 2012 | 170 | 0.160 |
Why?
| | Starch | 1 | 2019 | 22 | 0.150 |
Why?
| | Contraceptive Agents | 1 | 2020 | 65 | 0.150 |
Why?
| | Amputees | 1 | 2021 | 98 | 0.150 |
Why?
| | Aged | 15 | 2025 | 25913 | 0.150 |
Why?
| | Nutritive Value | 1 | 2019 | 38 | 0.150 |
Why?
| | Sweating | 1 | 2019 | 41 | 0.150 |
Why?
| | Metabolomics | 2 | 2026 | 727 | 0.150 |
Why?
| | Cross-Sectional Studies | 6 | 2023 | 5868 | 0.150 |
Why?
| | Parathyroid Hormone | 1 | 2019 | 112 | 0.150 |
Why?
| | Inpatients | 1 | 2023 | 545 | 0.140 |
Why?
| | Adipocytes | 2 | 2018 | 223 | 0.140 |
Why?
| | Hospitals | 1 | 2023 | 730 | 0.140 |
Why?
| | Telerehabilitation | 1 | 2019 | 43 | 0.140 |
Why?
| | Proof of Concept Study | 1 | 2018 | 85 | 0.140 |
Why?
| | Body Temperature | 2 | 2010 | 229 | 0.140 |
Why?
| | Kidney | 1 | 2026 | 1495 | 0.140 |
Why?
| | Postprandial Period | 3 | 2020 | 118 | 0.140 |
Why?
| | Brain Mapping | 3 | 2016 | 536 | 0.130 |
Why?
| | Guideline Adherence | 1 | 2022 | 589 | 0.130 |
Why?
| | Artificial Limbs | 1 | 2021 | 203 | 0.130 |
Why?
| | High-Intensity Interval Training | 1 | 2018 | 46 | 0.130 |
Why?
| | Time-to-Treatment | 1 | 2019 | 243 | 0.130 |
Why?
| | Liver | 1 | 2026 | 1887 | 0.130 |
Why?
| | Postmenopause | 1 | 2019 | 391 | 0.130 |
Why?
| | Diet, Reducing | 3 | 2025 | 91 | 0.130 |
Why?
| | Pilot Projects | 5 | 2022 | 1886 | 0.130 |
Why?
| | Computer Storage Devices | 1 | 2016 | 2 | 0.120 |
Why?
| | Tachycardia, Ventricular | 1 | 2018 | 181 | 0.120 |
Why?
| | Algorithms | 4 | 2015 | 1837 | 0.120 |
Why?
| | Self Report | 1 | 2021 | 872 | 0.120 |
Why?
| | Brain | 4 | 2025 | 2933 | 0.120 |
Why?
| | Gait | 2 | 2017 | 313 | 0.120 |
Why?
| | Odds Ratio | 1 | 2019 | 1075 | 0.120 |
Why?
| | Combined Modality Therapy | 1 | 2019 | 1266 | 0.120 |
Why?
| | Life Style | 2 | 2021 | 479 | 0.120 |
Why?
| | Homeostasis | 3 | 2019 | 640 | 0.120 |
Why?
| | Estrogens, Conjugated (USP) | 1 | 2015 | 52 | 0.110 |
Why?
| | Needs Assessment | 1 | 2018 | 404 | 0.110 |
Why?
| | Microbiota | 1 | 2023 | 781 | 0.110 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2025 | 1720 | 0.110 |
Why?
| | Defibrillators, Implantable | 1 | 2018 | 382 | 0.110 |
Why?
| | Leptin | 4 | 2025 | 245 | 0.110 |
Why?
| | Triglycerides | 2 | 2019 | 520 | 0.110 |
Why?
| | Skin | 1 | 2019 | 755 | 0.110 |
Why?
| | Sleep Stages | 1 | 2014 | 75 | 0.110 |
Why?
| | Veterans | 5 | 2025 | 1603 | 0.110 |
Why?
| | Blood Glucose | 4 | 2020 | 2327 | 0.110 |
Why?
| | Animals | 8 | 2025 | 38058 | 0.100 |
Why?
| | Diet Records | 2 | 2014 | 85 | 0.100 |
Why?
| | Health Status | 1 | 2019 | 836 | 0.100 |
Why?
| | Calcium | 1 | 2019 | 1183 | 0.100 |
Why?
| | Proteome | 1 | 2018 | 518 | 0.100 |
Why?
| | Muscle Fatigue | 1 | 2014 | 97 | 0.100 |
Why?
| | Nervous System Physiological Phenomena | 1 | 2013 | 22 | 0.100 |
Why?
| | Cell Phone | 1 | 2014 | 82 | 0.100 |
Why?
| | Task Performance and Analysis | 1 | 2014 | 198 | 0.090 |
Why?
| | Sound Spectrography | 2 | 2009 | 16 | 0.090 |
Why?
| | Blood Pressure | 1 | 2019 | 1769 | 0.090 |
Why?
| | Surveys and Questionnaires | 3 | 2023 | 6048 | 0.090 |
Why?
| | Urinalysis | 1 | 2012 | 80 | 0.090 |
Why?
| | Hydrogen | 1 | 2012 | 73 | 0.090 |
Why?
| | Insulin | 5 | 2020 | 2507 | 0.090 |
Why?
| | Area Under Curve | 1 | 2013 | 330 | 0.090 |
Why?
| | Smoking | 1 | 2019 | 1472 | 0.090 |
Why?
| | Lasers | 1 | 2012 | 132 | 0.090 |
Why?
| | Adipose Tissue | 3 | 2011 | 652 | 0.090 |
Why?
| | Hot Temperature | 2 | 2018 | 407 | 0.090 |
Why?
| | Case-Control Studies | 4 | 2021 | 3604 | 0.090 |
Why?
| | Sex Factors | 2 | 2014 | 2112 | 0.080 |
Why?
| | Aged, 80 and over | 5 | 2021 | 8265 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 4 | 2025 | 3863 | 0.080 |
Why?
| | Nerve Net | 1 | 2013 | 285 | 0.080 |
Why?
| | Physical Phenomena | 1 | 2010 | 13 | 0.080 |
Why?
| | Heart Failure | 1 | 2024 | 2323 | 0.080 |
Why?
| | Chronic Disease | 3 | 2024 | 1813 | 0.080 |
Why?
| | Muscle Proteins | 1 | 2012 | 244 | 0.080 |
Why?
| | Prospective Studies | 5 | 2021 | 7990 | 0.080 |
Why?
| | Collagen Type I | 2 | 2021 | 147 | 0.080 |
Why?
| | Diet Surveys | 1 | 2009 | 91 | 0.070 |
Why?
| | Glycerol | 1 | 2009 | 90 | 0.070 |
Why?
| | Somatotypes | 1 | 2009 | 4 | 0.070 |
Why?
| | Spirometry | 1 | 2010 | 231 | 0.070 |
Why?
| | Pattern Recognition, Automated | 1 | 2009 | 74 | 0.070 |
Why?
| | Cues | 1 | 2011 | 326 | 0.070 |
Why?
| | Thermography | 1 | 2009 | 10 | 0.070 |
Why?
| | Validation Studies as Topic | 1 | 2009 | 23 | 0.070 |
Why?
| | Nutritional Requirements | 2 | 2024 | 76 | 0.070 |
Why?
| | Models, Biological | 3 | 2018 | 1821 | 0.070 |
Why?
| | Auscultation | 1 | 2008 | 4 | 0.070 |
Why?
| | Age Factors | 2 | 2007 | 3333 | 0.070 |
Why?
| | Kinetics | 1 | 2012 | 1627 | 0.070 |
Why?
| | Cerebral Cortex | 1 | 2011 | 464 | 0.070 |
Why?
| | HIV Infections | 1 | 2024 | 3154 | 0.070 |
Why?
| | Healthy Volunteers | 2 | 2019 | 215 | 0.070 |
Why?
| | Respiratory Function Tests | 1 | 2010 | 547 | 0.070 |
Why?
| | Dietary Supplements | 1 | 2012 | 576 | 0.070 |
Why?
| | Body Fat Distribution | 1 | 2007 | 45 | 0.070 |
Why?
| | Colorado | 3 | 2021 | 4564 | 0.070 |
Why?
| | Phosphorylation | 1 | 2012 | 1732 | 0.060 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2007 | 158 | 0.060 |
Why?
| | Rats, Wistar | 4 | 2011 | 451 | 0.060 |
Why?
| | Norepinephrine | 1 | 2007 | 196 | 0.060 |
Why?
| | Reference Values | 2 | 2012 | 797 | 0.060 |
Why?
| | Sensitivity and Specificity | 3 | 2012 | 1985 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2583 | 0.060 |
Why?
| | Dairy Products | 1 | 2005 | 31 | 0.060 |
Why?
| | Gene Expression Regulation | 2 | 2012 | 2608 | 0.060 |
Why?
| | Patient Selection | 1 | 2009 | 719 | 0.060 |
Why?
| | Actigraphy | 1 | 2026 | 145 | 0.060 |
Why?
| | Telemedicine | 2 | 2025 | 945 | 0.060 |
Why?
| | Transcription, Genetic | 1 | 2012 | 1496 | 0.060 |
Why?
| | Recovery of Function | 2 | 2025 | 707 | 0.060 |
Why?
| | Organ Size | 1 | 2026 | 463 | 0.050 |
Why?
| | Photoperiod | 2 | 2019 | 55 | 0.050 |
Why?
| | Gyrus Cinguli | 1 | 2025 | 96 | 0.050 |
Why?
| | Polysomnography | 2 | 2020 | 235 | 0.050 |
Why?
| | Parasympathetic Nervous System | 1 | 2004 | 26 | 0.050 |
Why?
| | Shift Work Schedule | 1 | 2024 | 10 | 0.050 |
Why?
| | Equipment Design | 2 | 2017 | 530 | 0.050 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2004 | 64 | 0.050 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2025 | 148 | 0.050 |
Why?
| | Treatment Outcome | 4 | 2025 | 11679 | 0.050 |
Why?
| | Clinical Trials as Topic | 1 | 2009 | 1053 | 0.050 |
Why?
| | Canada | 1 | 2025 | 428 | 0.050 |
Why?
| | Long QT Syndrome | 1 | 2005 | 69 | 0.050 |
Why?
| | Thrombophilia | 1 | 2024 | 88 | 0.050 |
Why?
| | Statistics as Topic | 1 | 2004 | 284 | 0.050 |
Why?
| | Impulsive Behavior | 1 | 2025 | 146 | 0.050 |
Why?
| | Adiposity | 3 | 2016 | 543 | 0.050 |
Why?
| | Adiponectin | 1 | 2025 | 244 | 0.050 |
Why?
| | Linear Models | 2 | 2018 | 854 | 0.050 |
Why?
| | Walk Test | 1 | 2023 | 80 | 0.050 |
Why?
| | Reaction Time | 1 | 2025 | 438 | 0.050 |
Why?
| | Integrases | 1 | 2024 | 122 | 0.050 |
Why?
| | Anaerobic Threshold | 1 | 2002 | 28 | 0.050 |
Why?
| | Sampling Studies | 1 | 2002 | 99 | 0.050 |
Why?
| | Sensation | 1 | 2022 | 55 | 0.050 |
Why?
| | Blood Coagulation | 1 | 2024 | 268 | 0.050 |
Why?
| | Hormones | 2 | 2016 | 134 | 0.050 |
Why?
| | Triazoles | 1 | 2024 | 184 | 0.050 |
Why?
| | Women's Health | 1 | 2004 | 310 | 0.050 |
Why?
| | Pyridones | 1 | 2024 | 199 | 0.040 |
Why?
| | Electromyography | 2 | 2014 | 415 | 0.040 |
Why?
| | Prefrontal Cortex | 1 | 2025 | 328 | 0.040 |
Why?
| | Satiation | 1 | 2021 | 28 | 0.040 |
Why?
| | Recurrence | 2 | 2019 | 1135 | 0.040 |
Why?
| | Self-Management | 1 | 2024 | 201 | 0.040 |
Why?
| | Osteocalcin | 1 | 2021 | 38 | 0.040 |
Why?
| | Craving | 1 | 2021 | 39 | 0.040 |
Why?
| | Perimenopause | 1 | 2022 | 66 | 0.040 |
Why?
| | Waist Circumference | 1 | 2021 | 139 | 0.040 |
Why?
| | Muscle Strength | 1 | 2024 | 330 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2025 | 488 | 0.040 |
Why?
| | Proteins | 2 | 2006 | 1021 | 0.040 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2021 | 146 | 0.040 |
Why?
| | Absorptiometry, Photon | 2 | 2016 | 276 | 0.040 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 17 | 0.040 |
Why?
| | Rats | 4 | 2011 | 5597 | 0.040 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 34 | 0.040 |
Why?
| | Disability Evaluation | 1 | 2021 | 310 | 0.040 |
Why?
| | Bone Resorption | 1 | 2019 | 80 | 0.040 |
Why?
| | Decision Trees | 1 | 2018 | 81 | 0.040 |
Why?
| | Mathematical Concepts | 1 | 2018 | 36 | 0.040 |
Why?
| | Acidosis | 1 | 2019 | 105 | 0.040 |
Why?
| | Feces | 1 | 2021 | 513 | 0.030 |
Why?
| | Patient Discharge | 1 | 2025 | 983 | 0.030 |
Why?
| | Humidity | 1 | 2018 | 52 | 0.030 |
Why?
| | Methanol | 1 | 2018 | 46 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2019 | 312 | 0.030 |
Why?
| | Solvents | 1 | 2018 | 113 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2022 | 1095 | 0.030 |
Why?
| | Europe | 1 | 2018 | 412 | 0.030 |
Why?
| | Health Promotion | 1 | 2023 | 774 | 0.030 |
Why?
| | Wrist | 1 | 2017 | 60 | 0.030 |
Why?
| | Lower Extremity | 1 | 2021 | 438 | 0.030 |
Why?
| | Materials Testing | 1 | 2018 | 354 | 0.030 |
Why?
| | Methods | 1 | 1996 | 69 | 0.030 |
Why?
| | Plasma | 1 | 2018 | 225 | 0.030 |
Why?
| | Maximal Voluntary Ventilation | 1 | 2016 | 9 | 0.030 |
Why?
| | Sex Characteristics | 1 | 2002 | 790 | 0.030 |
Why?
| | Equipment and Supplies | 1 | 1996 | 35 | 0.030 |
Why?
| | Self Disclosure | 1 | 1996 | 62 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2021 | 2115 | 0.030 |
Why?
| | Carbon Isotopes | 1 | 1996 | 144 | 0.030 |
Why?
| | Proteomics | 1 | 2022 | 1195 | 0.030 |
Why?
| | Smartphone | 1 | 2016 | 102 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2016 | 361 | 0.030 |
Why?
| | Nontherapeutic Human Experimentation | 1 | 2014 | 3 | 0.030 |
Why?
| | Support Vector Machine | 1 | 2014 | 36 | 0.030 |
Why?
| | Disease Models, Animal | 3 | 2011 | 4557 | 0.030 |
Why?
| | Child | 3 | 2024 | 22633 | 0.030 |
Why?
| | Peptides | 1 | 2019 | 995 | 0.020 |
Why?
| | Logistic Models | 1 | 2018 | 2117 | 0.020 |
Why?
| | Risk Factors | 2 | 2020 | 10779 | 0.020 |
Why?
| | Machine Learning | 1 | 2018 | 585 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1047 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2023 | 17066 | 0.020 |
Why?
| | Anabolic Agents | 1 | 2012 | 12 | 0.020 |
Why?
| | Interviews as Topic | 1 | 1996 | 901 | 0.020 |
Why?
| | Sleep Wake Disorders | 1 | 2015 | 301 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1499 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 780 | 0.020 |
Why?
| | Muscle Contraction | 1 | 2014 | 429 | 0.020 |
Why?
| | United States | 2 | 2020 | 15966 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2015 | 2027 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2019 | 2832 | 0.020 |
Why?
| | Transcription Factors | 1 | 2019 | 1741 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2014 | 842 | 0.020 |
Why?
| | Photic Stimulation | 1 | 2011 | 264 | 0.020 |
Why?
| | Oxygen | 1 | 2016 | 995 | 0.020 |
Why?
| | Geriatric Assessment | 1 | 2012 | 233 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2014 | 582 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2018 | 2947 | 0.020 |
Why?
| | Fourier Analysis | 1 | 2009 | 41 | 0.020 |
Why?
| | Hydrostatic Pressure | 1 | 2009 | 30 | 0.020 |
Why?
| | Electric Impedance | 1 | 2009 | 111 | 0.020 |
Why?
| | Cognition | 1 | 2016 | 1266 | 0.020 |
Why?
| | Body Height | 1 | 2009 | 202 | 0.020 |
Why?
| | Arrhythmias, Cardiac | 1 | 2005 | 361 | 0.010 |
Why?
| | Mental Recall | 1 | 2003 | 222 | 0.010 |
Why?
| | Mice | 1 | 2019 | 18339 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2925 | 0.010 |
Why?
|
|
Melanson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|